Larimar Therapeutics LRMR SEC Filings

NASDAQ LRMR
$2.73 +0.04 (+1.49%)
At close: Nov 11, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Larimar Therapeutics, Inc. (LRMR) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
18-KCurrent Report0001193125-26-453586Nov 9, 2026 9:08 PM
24Insider Transaction0001193125-26-410719Oct 1, 2026 12:27 AM
33Insider Transaction0001193125-26-410715Oct 1, 2026 12:26 AM
48-KCurrent Report0001193125-26-407331Sep 29, 2026 8:06 PM
510-QQuarterly & Annual Report0001193125-26-331529Aug 4, 2026 11:12 AM
68-KCurrent Report0001193125-26-331516Aug 4, 2026 11:02 AM
74Insider Transaction0001193125-26-298523Jul 8, 2026 8:05 PM
88-KCurrent Report0001193125-26-286780Jun 29, 2026 10:33 AM
94Insider Transaction0001193805-26-000669May 20, 2026 12:02 AM
104Insider Transaction0001193125-26-232933May 20, 2026 10:03 PM
114Insider Transaction0001193125-26-232705May 20, 2026 8:30 PM
124Insider Transaction0001193125-26-232667May 20, 2026 8:28 PM
134Insider Transaction0001193125-26-232657May 20, 2026 8:24 PM
144Insider Transaction0001193125-26-232644May 20, 2026 8:21 PM
158-KCurrent Report0001193125-26-230852May 19, 2026 8:27 PM
16SCHEDULE 13GBeneficial Ownership Report0001140361-26-021322May 14, 2026 8:23 PM
1710-QQuarterly & Annual Report0001193125-26-224087May 14, 2026 8:18 PM
188-KCurrent Report0001193125-26-222746May 14, 2026 11:02 AM
19SCHEDULE 13GBeneficial Ownership Report0001104659-26-053218Apr 30, 2026 10:17 PM
20ARSOthers0001193125-26-163954Apr 20, 2026 8:08 PM
21DEF 14AOthers0001193125-26-163942Apr 20, 2026 8:06 PM
22PRE 14AOthers0001193125-26-151258Apr 10, 2026 8:09 PM
23S-8Prospectus0001193125-26-116159Mar 19, 2026 9:03 PM
2410-KQuarterly & Annual Report0001193125-26-115878Mar 19, 2026 7:41 PM
258-KCurrent Report0001193125-26-115119Mar 19, 2026 11:04 AM
268-KCurrent Report0001193125-26-098493Mar 9, 2026 8:08 PM
27SCHEDULE 13DBeneficial Ownership Report0001193805-26-000206Mar 2, 2026 12:46 AM
284Insider Transaction0001193805-26-000205Mar 2, 2026 12:46 AM
294Insider Transaction0001193125-26-085515Mar 2, 2026 9:30 PM
304Insider Transaction0001193125-26-085514Mar 2, 2026 9:30 PM
314Insider Transaction0001193125-26-085510Mar 2, 2026 9:30 PM
328-KCurrent Report0001193125-26-077646Feb 27, 2026 10:48 PM
33424B5Prospectus0001193125-26-076775Feb 26, 2026 9:20 PM
34424B5Prospectus0001193125-26-071493Feb 25, 2026 9:05 PM
358-KCurrent Report0001193125-26-065186Feb 24, 2026 12:02 PM
36SCHEDULE 13GBeneficial Ownership Report0001346824-26-000047Feb 17, 2026 9:33 PM
37SCHEDULE 13GBeneficial Ownership Report0001140361-26-005033Feb 12, 2026 9:36 PM
384Insider Transaction0001193125-26-024833Jan 27, 2026 10:04 PM
394Insider Transaction0001193125-26-024832Jan 27, 2026 10:04 PM
404Insider Transaction0001193125-26-024826Jan 27, 2026 10:04 PM
414Insider Transaction0001193125-26-024824Jan 27, 2026 10:03 PM
428-KCurrent Report0001193125-26-018664Jan 22, 2026 12:00 PM
438-KCurrent Report0001193125-26-010409Jan 12, 2026 9:18 PM
448-KCurrent Report0001193125-25-321738Dec 17, 2025 1:00 PM
458-KCurrent Report0001193125-25-273217Nov 10, 2025 12:01 PM
46SCHEDULE 13GBeneficial Ownership Report0001104659-25-107757Nov 6, 2025 9:17 PM
4710-QQuarterly & Annual Report0001193125-25-266969Nov 5, 2025 9:15 PM
488-KCurrent Report0001193125-25-265702Nov 5, 2025 12:03 PM
498-KCurrent Report0001193125-25-237998Oct 14, 2025 11:00 AM
508-KCurrent Report0001193125-25-221538Sep 29, 2025 11:00 AM
...

Larimar Therapeutics, Inc. SEC Filings API

Pull Larimar Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=LRMR&formtype=10-K,10-Q&api_key=YOUR_API_KEY